Beyond Air (XAIR) Operating Income (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.90% |
| Sep 30, 2025 | -0.58% |
| Jun 30, 2025 | -6.18% |
| Mar 31, 2025 | 34.50% |
| Dec 31, 2024 | 14.66% |
| Sep 30, 2024 | 5.50% |
| Jun 30, 2024 | -7.49% |
| Mar 31, 2024 | 25.52% |
| Dec 31, 2023 | 3.26% |
| Sep 30, 2023 | -10.46% |
| Jun 30, 2023 | -13.48% |
| Mar 31, 2023 | 0.15% |
| Dec 31, 2022 | -11.01% |
| Sep 30, 2022 | -10.32% |
| Jun 30, 2022 | 44.01% |
| Mar 31, 2022 | -172.92% |
| Dec 31, 2021 | -20.72% |
| Sep 30, 2021 | 5.92% |
| Jun 30, 2021 | -30.93% |
| Mar 31, 2021 | 10.36% |
| Dec 31, 2020 | -13.07% |
| Sep 30, 2020 | 24.70% |
| Jun 30, 2020 | -25.50% |
| Mar 31, 2020 | -10.94% |
| Dec 31, 2019 | -10.98% |
| Sep 30, 2019 | -10.07% |
| Jun 30, 2019 | -210.39% |
| Mar 31, 2019 | 246.24% |
| Dec 31, 2018 | 0.45% |
| Sep 30, 2018 | -37.42% |
| Jun 30, 2018 | 28.04% |
| Mar 31, 2018 | -202.63% |
| Dec 31, 2017 | 215.61% |
| Sep 30, 2017 | 32.93% |
| Jun 30, 2017 | -185.99% |
| Mar 31, 2017 | 678.98% |
| Dec 31, 2016 | -268.86% |
| Sep 30, 2016 | 73.32% |
| Jun 30, 2016 | 32.18% |